bioRxivNeurosciencePreprint
Restoring hippocampal sharp-wave ripples under glutamate transporter dysfunction
Abstract
Disruption of glutamate homeostasis is believed to contribute to the early progression of Alzheimers disease (AD) and associated neurodegeneration. Soluble amyloid-{beta} oligomers impair excitatory amino acid transporters (EAATs), reducing glutamate clearance, while also enhancing glutamate release from neurons and astrocytes. Together, these effects produce persistent glutamatergic dysregulation that disrupts synaptic and network function. Here, we asked whether the effects of EAAT attenuation can be mitigated through ion-channel modulation. TBOA, a selective EAAT inhibitor, was used to model early-stage glutamatergic dysregulation. TBOA reduced the local field potential amplitude of hippocampal sharp-wave ripples (SWRs) in mouse hippocampal slices, suggesting that glutamate accumulation disrupts network synchrony. Calcium imaging further showed that TBOA diminished SWR-associated population calcium transients while promoting spontaneous calcium transients in individual neurons, indicating a shift from coordinated population activity toward disorganized cellular activity. KCNQ-channel openers ML213 and ICA-27243 partially restored the TBOA-induced decline in SWR amplitude. In contrast, similar restorative effects were not observed following modulation of other ion channels, including blockade of AMPA and NMDA receptors or HCN/Ih channels, or activation of large-conductance Ca2+-activated K+ (BK) channels and G-protein-activated inwardly rectifying potassium (GIRK) channels. Together, these findings suggest that KCNQ-channel openers may occupy a unique position in mitigating glutamate-related hyperexcitability during early AD-associated network dysfunction.
- organism: mouse
- assay: electronic health records
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimers Disease
Louis John Kolling, Nagalakshmi Balasubramanian, … Catherine Anne Marcinkiewcz·Alzheimer s & DementiaPeer-reviewed·May 1, 2026
- Loss of glutamate transporter eaat2a leads to aberrant neuronal excitability, recurrent epileptic seizures and hypoactivity
Adriana L. Hotz, Ahmed Jamali, … Stephan C. F. Neuhauss·GliaPeer-reviewed·Oct 30, 2021
- Glutamate uptake is transiently compromised in the perilesional cortex following controlled cortical impact
Jacqueline P Garcia, Moritz Armbruster, … Chris G. Dulla·Cerebral CortexPeer-reviewed·Jan 28, 2025
- Upregulated Ca2+ release from the endoplasmic reticulum leads to impaired presynaptic function in Alzheimer's disease
Temitope Adeoye, Syed Islamuddin Shah, … Ghanim Ullah·bioRxiv·Apr 21, 2022
- Expression of a modified astrocytic glutamate transporter alleviates Huntington hypokinesia, promotes synaptic glutamate clearance and counteracts potentially adverse EAAT2 interactions
Stefan Hirschberg, Anton Dvorzhak, … Rosemarie Grantyn·bioRxiv·Sep 17, 2020
- Ataxia-linked SLC1A3 mutations alter EAAT1 chloride channel activity and glial regulation of CNS function
Qianyi Wu, Azman Akhter, … Renae M. Ryan·Journal of Clinical InvestigationPeer-reviewed·Feb 15, 2022